AC Immune SA (ACIU)

AC Immune Statistics

Total Valuation

AC Immune has a market cap or net worth of $326.51 million. The enterprise value is $196.33 million.

Market Cap	326.51M
Enterprise Value	196.33M

Important Dates

The last earnings date was Tuesday, November 4, 2025, before market open.

Earnings Date	Nov 4, 2025
Ex-Dividend Date	n/a

Share Statistics

AC Immune has 98.94 million shares outstanding. The number of shares has increased by 3.27% in one year.

Current Share Class	98.94M
Shares Outstanding	98.94M
Shares Change (YoY)	+3.27%
Shares Change (QoQ)	-1.51%
Owned by Insiders (%)	2.99%
Owned by Institutions (%)	5.07%
Float	39.29M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	59.91
Forward PS	305.72
PB Ratio	4.18
P/TBV Ratio	21.65
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	35.81
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.16, with a Debt / Equity ratio of 0.07.

Current Ratio	1.16
Quick Ratio	1.12
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-408.24

Financial Efficiency

Return on equity (ROE) is -74.63% and return on invested capital (ROIC) is -45.59%.

Return on Equity (ROE)	-74.63%
Return on Assets (ROA)	-21.97%
Return on Invested Capital (ROIC)	-45.59%
Return on Capital Employed (ROCE)	-99.66%
Revenue Per Employee	$31,878
Profits Per Employee	-$524,035
Employee Count	172
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

In the past 12 months, AC Immune has paid $3,762 in taxes.

Income Tax	3,762
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +8.09% in the last 52 weeks. The beta is 1.59, so AC Immune's price volatility has been higher than the market average.

Beta (5Y)	1.59
52-Week Price Change	+8.09%
50-Day Moving Average	2.93
200-Day Moving Average	2.29
Relative Strength Index (RSI)	53.34
Average Volume (20 Days)	398,559

Short Selling Information

Short Interest	1.58M
Short Previous Month	1.64M
Short % of Shares Out	3.31%
Short % of Float	n/a
Short Ratio (days to cover)	5.21

Income Statement

In the last 12 months, AC Immune had revenue of $5.48 million and -$90.13 million in losses. Loss per share was -$0.91.

Revenue	5.48M
Gross Profit	-72.99M
Operating Income	-91.64M
Pretax Income	-90.13M
Net Income	-90.13M
EBITDA	-89.86M
EBIT	-91.64M
Loss Per Share	-$0.91

Balance Sheet

The company has $136.03 million in cash and $5.85 million in debt, giving a net cash position of $130.19 million or $1.32 per share.

Cash & Cash Equivalents	136.03M
Total Debt	5.85M
Net Cash	130.19M
Net Cash Per Share	$1.32
Equity (Book Value)	78.31M
Book Value Per Share	0.79
Working Capital	19.39M

Cash Flow

In the last 12 months, operating cash flow was -$58.72 million and capital expenditures -$1.11 million, giving a free cash flow of -$59.25 million.

Operating Cash Flow	-58.72M
Capital Expenditures	-1.11M
Free Cash Flow	-59.25M
FCF Per Share	-$0.60

Margins

Gross Margin	n/a
Operating Margin	-1,671.43%
Pretax Margin	-1,643.82%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AC Immune does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.27%
Shareholder Yield	-3.27%
Earnings Yield	-27.61%
FCF Yield	-18.15%

Analyst Forecast

The average price target for AC Immune is $10.00, which is 203.03% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.00
Price Target Difference	203.03%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	56.24%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1